- Home
- Publications
- Publication Search
- Publication Details
Title
Immune activation and HIV persistence
Authors
Keywords
-
Journal
Current Opinion in HIV and AIDS
Volume 8, Issue 3, Pages 211-216
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-02-27
DOI
10.1097/coh.0b013e32835f9788
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination
- (2014) A. C. Finnefrock et al. JOURNAL OF IMMUNOLOGY
- Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery
- (2012) Marta Massanella et al. AIDS
- Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults
- (2012) Caryn G. Morse et al. AIDS
- Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution
- (2012) M. Zeng et al. BLOOD
- A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection
- (2012) Hiroyu Hatano et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Microbial translocation in HIV infection: causes, consequences and treatment opportunities
- (2012) Netanya G. Sandler et al. NATURE REVIEWS MICROBIOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
- (2012) Daniel A. Duprez et al. PLoS One
- Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial
- (2012) Jason V. Baker et al. PLoS One
- Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy
- (2012) Ming Zeng et al. PLoS Pathogens
- Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
- (2011) Peter W. Hunt et al. AIDS
- Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV
- (2011) Laura W Musselwhite et al. AIDS
- Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study
- (2011) Josep M Llibre et al. ANTIVIRAL THERAPY
- A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
- (2011) Hiroyu Hatano et al. JOURNAL OF INFECTIOUS DISEASES
- Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
- (2011) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
- (2011) Anuradha Ganesan et al. JOURNAL OF INFECTIOUS DISEASES
- Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death
- (2011) David R. Boulware et al. JOURNAL OF INFECTIOUS DISEASES
- Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells
- (2011) Michael M. Lederman et al. JOURNAL OF INFECTIOUS DISEASES
- Soluble CD163 Made by Monocyte/Macrophages Is a Novel Marker of HIV Activity in Early and Chronic Infection Prior to and After Anti-retroviral Therapy
- (2011) Tricia H. Burdo et al. JOURNAL OF INFECTIOUS DISEASES
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
- (2011) Netanya G. Sandler et al. JOURNAL OF INFECTIOUS DISEASES
- An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses
- (2011) F. O. Pettersen et al. JOURNAL OF VIROLOGY
- Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial
- (2011) A Gori et al. Mucosal Immunology
- Effect of Probiotic Bacteria on Microbial Host Defense, Growth, and Immune Function in Human Immunodeficiency Virus Type-1 Infection
- (2011) Susanna Cunningham-Rundles et al. Nutrients
- Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
- (2010) Steven A Yukl et al. AIDS
- Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral Therapy
- (2010) D. McMahon et al. CLINICAL INFECTIOUS DISEASES
- Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
- (2010) Jacqueline Neuhaus et al. JOURNAL OF INFECTIOUS DISEASES
- Reduction of Immune Activation with Chloroquine Therapy during Chronic HIV Infection
- (2010) S. M. Murray et al. JOURNAL OF VIROLOGY
- HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
- (2010) Maria J Buzón et al. NATURE MEDICINE
- The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
- (2010) Rajesh T. Gandhi et al. PLOS MEDICINE
- Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
- (2010) Jacob D. Estes et al. PLoS Pathogens
- Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation
- (2009) N. T. Funderburg et al. BLOOD
- Serum Immune Activation Markers Are Persistently Increased in Patients with HIV Infection after 6 Years of Antiretroviral Therapy despite Suppression of Viral Replication and Reconstitution of CD4+T Cells
- (2009) Martyn A. French et al. JOURNAL OF INFECTIOUS DISEASES
- Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection
- (2009) Wei Jiang et al. JOURNAL OF INFECTIOUS DISEASES
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Enhancing SIV-specific immunity in vivo by PD-1 blockade
- (2008) Vijayakumar Velu et al. NATURE
- Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut
- (2008) Manuela Raffatellu et al. NATURE MEDICINE
- Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
- (2008) Lewis H Kuller et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started